Antoun Toubaji

2.7k total citations
29 papers, 2.0k citations indexed

About

Antoun Toubaji is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Antoun Toubaji has authored 29 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 17 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Antoun Toubaji's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Renal cell carcinoma treatment (4 papers). Antoun Toubaji is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (7 papers) and Renal cell carcinoma treatment (4 papers). Antoun Toubaji collaborates with scholars based in United States, Myanmar and Spain. Antoun Toubaji's co-authors include George J. Netto, Angelo M. De Marzo, Alan K. Meeker, Roula Albadine, Michael C. Haffner, Srinivasan Yegnasubramanian, William G. Nelson, Alcides Chaux, David Esopi and Jessica Hicks and has published in prestigious journals such as Nature Communications, Nature Genetics and Journal of Clinical Oncology.

In The Last Decade

Antoun Toubaji

28 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antoun Toubaji United States 19 1.3k 926 397 395 200 29 2.0k
Yuzo Furuya Japan 22 923 0.7× 731 0.8× 510 1.3× 359 0.9× 133 0.7× 83 1.9k
Shi‐Ming Tu United States 19 857 0.7× 1.1k 1.2× 781 2.0× 397 1.0× 361 1.8× 72 2.1k
Yuichi Ishikawa Japan 23 1.4k 1.0× 472 0.5× 476 1.2× 597 1.5× 145 0.7× 113 2.5k
Yajun Yi United States 22 969 0.7× 320 0.3× 389 1.0× 490 1.2× 145 0.7× 31 1.7k
Vladimir Bilim Japan 25 1.4k 1.0× 475 0.5× 583 1.5× 397 1.0× 255 1.3× 81 2.1k
Marie‐Pierre Simon France 21 1.1k 0.8× 439 0.5× 429 1.1× 555 1.4× 259 1.3× 31 1.9k
Xiangtian Kong United States 15 830 0.6× 1.2k 1.3× 247 0.6× 351 0.9× 121 0.6× 20 1.8k
Jin Eun Choi South Korea 28 1.5k 1.2× 569 0.6× 683 1.7× 593 1.5× 117 0.6× 96 2.2k
Linda Xu United States 20 891 0.7× 428 0.5× 264 0.7× 383 1.0× 72 0.4× 27 1.6k
Hiroya Oka Japan 15 1.1k 0.9× 350 0.4× 426 1.1× 252 0.6× 192 1.0× 52 1.7k

Countries citing papers authored by Antoun Toubaji

Since Specialization
Citations

This map shows the geographic impact of Antoun Toubaji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antoun Toubaji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antoun Toubaji more than expected).

Fields of papers citing papers by Antoun Toubaji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antoun Toubaji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antoun Toubaji. The network helps show where Antoun Toubaji may publish in the future.

Co-authorship network of co-authors of Antoun Toubaji

This figure shows the co-authorship network connecting the top 25 collaborators of Antoun Toubaji. A scholar is included among the top collaborators of Antoun Toubaji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antoun Toubaji. Antoun Toubaji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Webster, Bradley R., Christopher J. Ricketts, Cathy D. Vocke, et al.. (2024). Molecular Characterization of Metastatic Oncocytoma With Exceptional Response to Treatment: A Case Report. JCO Precision Oncology. 8(8). e2400188–e2400188.
2.
3.
Toubaji, Antoun, et al.. (2019). Identification of the PTEN-ARID4B-PI3K pathway reveals the dependency on ARID4B by PTEN-deficient prostate cancer. Nature Communications. 10(1). 4332–4332. 39 indexed citations
4.
Toubaji, Antoun, et al.. (2017). A Retroperitoneal Serous Cystadenoma of Müllerian Origin Masquerading as a Massive Renal Cyst. Urology. 105. e9–e10. 3 indexed citations
5.
6.
Chaux, Alcides, Roula Albadine, Antoun Toubaji, et al.. (2011). Immunohistochemistry for ERG Expression as a Surrogate for TMPRSS2-ERG Fusion Detection in Prostatic Adenocarcinomas. The American Journal of Surgical Pathology. 35(7). 1014–1020. 119 indexed citations
7.
Toubaji, Antoun, Roula Albadine, Alan K. Meeker, et al.. (2011). Increased gene copy number of ERG on chromosome 21 but not TMPRSS2–ERG fusion predicts outcome in prostatic adenocarcinomas. Modern Pathology. 24(11). 1511–1520. 51 indexed citations
8.
Haffner, Michael C., Alcides Chaux, Alan K. Meeker, et al.. (2011). Global 5-hydroxymethylcytosine content is significantly reduced in tissue stem/progenitor cell compartments and in human cancers. Oncotarget. 2(8). 627–637. 362 indexed citations
9.
Lotan, Tamara L., Nilesh Gupta, Wenle Wang, et al.. (2011). ERG gene rearrangements are common in prostatic small cell carcinomas. Modern Pathology. 24(6). 820–828. 156 indexed citations
10.
Rahma, Osama E., Ramy Ibrahim, Antoun Toubaji, et al.. (2010). A pilot clinical trial testing mutant von Hippel-Lindau peptide as a novel immune therapy in metastatic Renal Cell Carcinoma. Journal of Translational Medicine. 8(1). 8–8. 25 indexed citations
11.
Sidana, Abhinav, Muwen Wang, Wasim H. Chowdhury, et al.. (2010). Does Valproic Acid Induce Neuroendocrine Differentiation in Prostate Cancer?. BioMed Research International. 2011(1). 607480–607480. 3 indexed citations
12.
Haffner, Michael C., Martin J. Aryee, Antoun Toubaji, et al.. (2010). Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nature Genetics. 42(8). 668–675. 450 indexed citations
13.
Albadine, Roula, Wenle Wang, Noel A. Brownlee, et al.. (2009). Topoisomerase II α Status in Renal Medullary Carcinoma: Immuno-Expression and Gene Copy Alterations of a Potential Target of Therapy. The Journal of Urology. 182(2). 735–740. 28 indexed citations
14.
Lotan, Tamara L., Antoun Toubaji, Roula Albadine, et al.. (2009). TMPRSS2-ERG gene fusions are infrequent in prostatic ductal adenocarcinomas. Modern Pathology. 22(3). 359–365. 49 indexed citations
15.
Albadine, Roula, Mathieu Latour, Antoun Toubaji, et al.. (2009). TMPRSS2–ERG gene fusion status in minute (minimal) prostatic adenocarcinoma. Modern Pathology. 22(11). 1415–1422. 43 indexed citations
16.
Nagpal, Jatin, Santanu Dasgupta, Sana Jadallah, et al.. (2008). Profiling the expression pattern of GPI transamidase complex subunits in human cancer. Modern Pathology. 21(8). 979–991. 44 indexed citations
17.
Goodwin, Andrew C., Sana Jadallah, Antoun Toubaji, et al.. (2008). Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues. The Prostate. 68(7). 766–772. 73 indexed citations
18.
Netto, George J., Yasutomo Nakai, Masashi Nakayama, et al.. (2008). Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors. Modern Pathology. 21(11). 1337–1344. 95 indexed citations
19.
Toubaji, Antoun, Maurizio Provenzano, Robert J. Behrens, et al.. (2008). Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers. Cancer Immunology Immunotherapy. 57(9). 1413–1420. 99 indexed citations
20.
Toubaji, Antoun, Sarah J. Hill, Masaki Terabe, et al.. (2007). The combination of GM-CSF and IL-2 as local adjuvant shows synergy in enhancing peptide vaccines and provides long term tumor protection. Vaccine. 25(31). 5882–5891. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yuzo Furuya Breakdown of academic impact, for papers by Shi‐Ming Tu Breakdown of academic impact, for papers by Yuichi Ishikawa Breakdown of academic impact, for papers by Yajun Yi Breakdown of academic impact, for papers by Vladimir Bilim Breakdown of academic impact, for papers by Marie‐Pierre Simon Breakdown of academic impact, for papers by Xiangtian Kong Breakdown of academic impact, for papers by Jin Eun Choi Breakdown of academic impact, for papers by Linda Xu Breakdown of academic impact, for papers by Hiroya Oka
Rankless by CCL
2026